- Home
- CDTX vs BNY Comparison
CDTX vs BNY Comparison
Compare CDTX & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- BNY
- Stock Information
- Founded
- CDTX 2012
- BNY 2001
- Country
- CDTX United States
- BNY United States
- Employees
- CDTX N/A
- BNY N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- BNY Trusts Except Educational Religious and Charitable
- Sector
- CDTX Health Care
- BNY Finance
- Exchange
- CDTX Nasdaq
- BNY Nasdaq
- Market Cap
- CDTX 259.0M
- BNY 249.4M
- IPO Year
- CDTX 2015
- BNY N/A
- Fundamental
- Price
- CDTX $17.82
- BNY $10.30
- Analyst Decision
- CDTX Strong Buy
- BNY
- Analyst Count
- CDTX 8
- BNY 0
- Target Price
- CDTX $38.00
- BNY N/A
- AVG Volume (30 Days)
- CDTX 156.0K
- BNY 52.7K
- Earning Date
- CDTX 05-14-2025
- BNY 01-01-0001
- Dividend Yield
- CDTX N/A
- BNY 3.93%
- EPS Growth
- CDTX N/A
- BNY N/A
- EPS
- CDTX N/A
- BNY N/A
- Revenue
- CDTX $1,275,000.00
- BNY N/A
- Revenue This Year
- CDTX N/A
- BNY N/A
- Revenue Next Year
- CDTX N/A
- BNY N/A
- P/E Ratio
- CDTX N/A
- BNY N/A
- Revenue Growth
- CDTX N/A
- BNY N/A
- 52 Week Low
- CDTX $10.00
- BNY $8.60
- 52 Week High
- CDTX $28.42
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- CDTX 33.85
- BNY 50.24
- Support Level
- CDTX $19.83
- BNY $10.17
- Resistance Level
- CDTX $23.76
- BNY $10.39
- Average True Range (ATR)
- CDTX 1.58
- BNY 0.10
- MACD
- CDTX -0.53
- BNY 0.01
- Stochastic Oscillator
- CDTX 5.11
- BNY 72.06
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr has an investment objective to provide current income exempt from regular U.S. federal income tax and New York State and New York City personal income taxes. The Trust seeks to achieve its investment objective by investing primarily in municipal bonds exempt from U.S. federal income taxes and New York State and New York City personal income taxes.